Techniques of disease activity assessment in Crohn's disease

Seminars in Colon and Rectal Surgery

Volumn 12, Issue 1, 2001, Pages 16-21

  Poritz, L S ^a   Koltun, W A ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL FEATURE; CROHN DISEASE; DIAGNOSTIC TEST; DISEASE ACTIVITY; DISEASE SEVERITY; PATHOPHYSIOLOGY; RECURRENT DISEASE; RELAPSE; REVIEW; TREATMENT OUTCOME;

EID: 0035099307     PISSN: 10431489     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Predicting relapses of Crohn's disease, clouds in a crystal ball
2. Development of a Crohn's disease activity index, National Cooperative Crohn's Disease Study
3. The Crohn's disease activity index, its derivatives and the inflammatory bowel disease questionnaire: A review of instruments to assess Crohn's disease
4. Is the Crohn's disease activity index outdated? Yes. Is it the gold standard that clinicians should use?
5. A simple index of Crohn's disease activity
6. An index of inflammatory activity in patients with Crohn's disease
7. Clinical relevance of serum interleukin-6 in Crohn's disease: Single point measurements, therapy monitoring, and prediction of clinical relapse
8. Fecal a1-antitrypsin measurement: An indicator of Crohn's disease activity
9. CD45RO expression on circulating CD19+ B cells in Crohn's disease correlates with intestinal permeability
10. Intestinal permeability and postheparin plasma diamine oxidase activity in the prediction of Crohn's disease relapse
11. Predictors of acute relapse of Crohn's disease: A laboratory and clinical study
12. Laboratory assessment of inflammatory bowel disease
13. Soluble interleukin-2 receptor in Crohn's disease, assessment of disease activity and prediction of relapse
14. Assessment of appropriate laboratory measurements to supplement the Crohn's disease activity index
15. Advances in the assessment of disease activity in inflammatory bowel disease
16. Importance of laboratory parameters in the evaluation of Crohn's disease activity
17. The clinical significance of serum C reactive protein levels in Crohn's disease
18. Endoscopic monitoring of Crohn's disease treatment: A prospective, randomized clinical trial
19. Development and validation of an endoscopic index of the severity for Crohn's disease: A prospective multicenter study
20. 111Indium autologous mixed leukocyte scanning accurately assess disease extent and activity in Crohn's disease?
21. Early and delayed indium 111 leukocyte imaging in Crohn's disease
22. Scintigraphic assessment of bowel involvement and disease activity in Crohn's disease using technetium 99m-hexamethyl propylene amine oxine as leukocyte label
23. Quantification of inflammatory bowel disease activity using technetium-99m HMPAO labelled leucocyte single photon emission computerized tomography (SPECT)
24. Pediatric inflammatory bowel disease: Assessment with scintigraphy with 99mTc white blood cells
25. Quantitative fecal indium 111-labeled leukocyte excretion in the assessment of disease in Crohn's disease
26. Intestinal permeability and the prediction of relapse in Crohn's disease
27. Bowel permeability is improved in Crohn's disease after ileocolectomy
28. 51Cr]EDTA and inflammatory activity in asymptomatic patients with Crohn's disease
29. Intestinal permeability test as a predictor of clinical course in Crohn's disease
30. Mesenteric blood flow is related to disease activity and risk of relapse in Crohn's disease: A prospective follow-up study